Keybanc Maintains Overweight on HealthEquity, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Scott Schoenhaus maintains an Overweight rating on HealthEquity (HQY) and raises the price target from $85 to $95.
March 22, 2024 | 5:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst Scott Schoenhaus maintains an Overweight rating on HealthEquity and raises the price target from $85 to $95.
The increase in price target by Keybanc reflects a positive outlook on HealthEquity's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100